Prospective Evaluation of a Quality Improvement Initiative to Improve Breast Cancer Treatment Timeliness in Mexico
Cancer Medicine · 2026-11 · 15 (11)
DOI: 10.1002/cam4.72406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 17.11.2026. Verfasst von Miguel Zambrano Lucio und 3 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación Mexicana para la Salud.
Abstract (Originalsprache)
Introduction
Delays in Breast Cancer diagnosis and treatment remain common in low and middle‐income countries (LMICs), yet evidence on the effectiveness and sustainability of quality improvement (QI) initiatives in resource‐constrained cancer centers is limited. We prospectively evaluated a quality improvement (QI) initiative designed to reduce treatment delays at a national cancer center in Mexico and assessed the sustainment of its effects. Materials and Methods We analyzed time intervals for 933 newly diagnosed breast cancer patients presenting between September 2023 and December 2024 across three phases: pre‐intervention, active intervention, and sustainment. The QI initiative was informed by a prior needs assessment and included workflow modifications, systematic monitoring and feedback on time‐to‐care metrics, and monthly multidisciplinary meetings. Outcomes included median Total Time‐to‐Treatment (TTT), Time‐to‐Diagnosis (TTD), Time‐to‐Tumor Board (TTB), and Time‐from‐Diagnosis‐to‐Treatment (TDT).
Results
Median TTT decreased from 51 days at baseline to 43 days during the intervention phase ( p < 0.001) but returned to 51 days during sustainment. TTB showed consistent improvement, decreasing from 34 days at baseline to 28 days during the intervention and remained shorter during sustainment (27 days, p < 0.001 vs. baseline). TTD did not improve during active implementation but decreased during sustainment (19 days, p < 0.001). TDT did not change significantly during the intervention (26 vs. 22 days) but increased to 30 days during sustainment ( p < 0.001 vs. intervention). Monthly patient volume increased by 24.1% between the baseline and sustainment periods, coinciding with the loss of overall TTT improvement.
Conclusions
This low‐cost QI initiative produced meaningful reductions in BC treatment delays and achieved sustained improvements in Time‐to‐Tumor Board. However, gains in overall treatment timeliness were not sustained as patient volume and external system pressures exceeded institutional capacity. These findings underscore both the potential and limitations of workflow‐focused QI initiatives in resource‐constrained cancer centers and underscore the importance of evaluating sustainment alongside short‐term effectiveness.
Förderung
- Fundación Mexicana para la Salud
Zitieren
APA
Lucio, M. Z., Hernández, G. M., Ortiz‐Rodríguez, S., & Saldaña, K. U. (2026). Prospective Evaluation of a Quality Improvement Initiative to Improve Breast Cancer Treatment Timeliness in Mexico. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72406
Vancouver
Lucio MZ, Hernández GM, Ortiz‐Rodríguez S, Saldaña KU. Prospective Evaluation of a Quality Improvement Initiative to Improve Breast Cancer Treatment Timeliness in Mexico. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72406
BibTeX
@article{Lucio2026,
author = {Lucio, Miguel Zambrano and Hernández, Gardenia Mayo and Ortiz‐Rodríguez, Saraí and Saldaña, Karla Unger},
title = {Prospective Evaluation of a Quality Improvement Initiative to Improve Breast Cancer Treatment Timeliness in Mexico},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/cam4.72406}
}
EUVIMED